D-Day
-737 daysScientific Program
Day 1 June 2nd (Wednesday)
Time (KST) | Topic Chair/Speaker |
---|---|
Special Symposium - Pioneers in Immune Cell Therapy | |
09:00-11:00 | Main Symposium: Emerging Stars in Immune Cell Therapy
Chair: Yu Kyeong Hwang (Green Cross LabCell Inc., Korea) |
09:00–09:30 | Enhanced CAR-T cell therapy using Converter & CLIP CAR platforms
Kyungho Choi (TiCARos Inc., Korea) |
09:30–10:00 | Development of novel anti-CD19 CAR T cells resistant to PD-1 and TIGIT-mediated immune suppression
Hyung Cheol Kim (CuroCell Inc.,Korea) |
Chair: Kyungho Choi (TiCARos Inc., Korea) |
|
10:00–10:30 | Provability and challenges of CAR-NK cell therapy beyond CAR-T cells
Yu Kyeong Hwang (Green Cross LabCell Inc., Korea) |
10:30–11:00 | Expanded human umbilical cord blood Myeloid-derived suppressor cells ameliorate graft versus host disease by immunosuppressive function
Hyun-Jung Sohn (ViGenCell Inc., Korea) |
11:00-11:10 | Coffee Break |
11:10-12:10 | Keynote Lecture: “From Bench to Bedside”: The Story of a Big Tree
Chair: Jeehee Youn (Hanyang University, Korea) |
11:10–12:00 | Anti-Cancer TCR T Therapeutics: From Bench to Bedside
Byoung S. Kwon (Eutilex Co.,Ltd., Korea) |
12:00–12:10 | Gratitude ceremony |
12:10-13:10 | Luncheon Symposium 1 - Abbvie
Chair: Sang-Il Lee (Gyeongsang University, Korea) |
Introduction of new JAK inhibitor Upadacitinib for inadequate responders on established therapies in Rheumatoid Arthritis
Seung-Ki Kwok (The Catholic University, Korea) |
|
13:10-13:20 | President's Welcome Address & KAI-Genexine Awards Ceremony |
13:20-14:20 | Plenary Lecture 1: KAI-Genexine Grand Achievement Award Lecture
Chair: Wan-Uk Kim (The Catholic University, Korea) |
13:20-14:10 | Microbial metabolites in the regulation of host immunity
Mi-Na Kweon (University of Ulsan, Korea) |
14:10-14:20 | Q&A |
14:20-14:30 | Coffee Break |
14:30-16:10 | Symposium 1 - Mucosal Immunology and Microbiota
*[Society for Mucosal Immunology] Chair: Myunghoo Kim (Pusan University, Korea), Sang-Uk Seo (The Catholic University, Korea) |
14:30-15:00 | Innate Lymphoid Cells: Regulation of generation and effector functions
Chang H. Kim (University of Michigan, USA) |
15:00-15:10 | Q&A |
15:10-15:40 | Understanding gut-lung axis for asthma control
Han-Ki Park (Kyungpook National University, Korea) |
15:40-16:10 | Location-specific diversity of microbiome in the gastrointestinal tract
Seong-Tshool Hong (Jeonbuk National University, Korea) |
16:10-16:20 | Coffee Break |
16:20-17:05 | Workshop 1 - Infection & Immunodeficiency
Chair: Nam-Hyuk Cho (Seoul National University, Korea) |
16:20-16:35 | Modulation of Il-27p28 production on T&B cells during infection
Jeongho Park (Kangwon University, Korea) |
16:35-16:50 | Mycobacterium tuberculosis Rv2626c-derived peptide as a therapeutic agent for sepsis
Chul-Su Yang (Hanyang University, Korea) |
16:50-17:05 | Successful Sirolimus Treatment for Korean Patients with Activated Phosphoinositide 3-kinase δ Syndrome 1: the First Case Series in Korea
Yae-Jean Kim (Sungkyunkwan University, Korea) |
17:05-17:20 | Coffee Break |
17:20-18:20 | Plenary Lecture 2 - Microbiota in Cancer
Chair: Sang Gyu Lee (Yonsei University, Korea) |
17:20-18:10 | Microbiota-centered interventions in immuno-oncology: research and prospects
Laurence Zitvogel (Gustave Roussy Cancer Center, France) |
18:10-18:20 | Q&A |
[Co-host] *